When Nikki Myers, 33, found a lump in her neck last fall, she visited an urgent care clinic. She learned she had ovarian ...

The T.E.A.L. (Tell Every Amazing Lady) walk/run in Prospect Park started 17 years ago, but this year, the nonprofit is ...

Former marathon runner Paula Radcliffe revealed she and her husband Gary Lough initially dismissed the early signs of ovarian ...

US ovarian cancer mortality rates declined from 1999 to 2020, but significant disparities remain across age, race, and geographic regions, highlighting the need for targeted public health efforts.

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...

Researchers identify PPP2R1A gene mutations as a new marker linked to better immunotherapy response and survival in ovarian ...

Disease-free and overall survival were comparable between paclitaxel- and cisplatin-based heated chemotherapy regimens in ...

Fat tissue secretes hormones known as adipokines. Patients with obesity have a larger amount of leptin than a normal ...

Ovarian cancer drug RC88 by RemeGen received FDA approval for Phase 2 clinical trials. Gynecologic oncologist Dr. Brian Slomovitz and other experts weighed in on the drug's potential.

Ovarian cancer is most common in older women after menopause. Most of the time, it’s not clear why a particular cancer happens. But some things that can make cancer more likely.

Stage IV ovarian cancer. The cancer has spread to distant areas. In stage IVA, it’s moved near your lungs. In stage IVB, the cancer is in the lymph nodes of your groin.